Investors Buy Large Volume of Centene Call Options (NYSE:CNC)

Centene Corporation (NYSE:CNC) was the target of unusually large options trading on Tuesday. Stock investors acquired 19,116 call options on the stock. This is an increase of approximately 100% compared to the average volume of 9,573 call options.

More Centene News

Here are the key news stories impacting Centene this week:

• Positive Sentiment: Q1 earnings & guidance beat — Centene reported a sizable EPS beat and raised its 2026 outlook, citing declining medical costs, steady premium growth and effective cost controls; that drove the initial rally. Centene Analysts Increase Their Forecasts Following Upbeat Q1 Earnings
• Positive Sentiment: Analyst upgrades and price-target lifts — Multiple brokerages moved targets higher (Truist, UBS, Bank of America raised ratings/targets), supporting momentum and investor confidence. Truist raises Centene price target to $58 UBS adjusts price target on Centene to $55
• Positive Sentiment: Unusual options activity — Heavy call buying was recorded around the report, indicating speculative and institutional bullish interest that can amplify intraday moves.
• Neutral Sentiment: Technicals/support — Chart analysis notes the stock found long-term support from prior lows, which may attract technical buyers but also invites profit-taking debate on rally extent. Stock Of The Day: Where Will The Centene Rally End?
• Neutral Sentiment: Earnings-call tone cautious — Management highlighted progress on cost controls and Medicaid, but was measured on membership trends and longer-term margin drivers; investors should watch upcoming quarters for sustainability. Centene Earnings Call: Big EPS Beat, Cautious Outlook
• Negative Sentiment: Legislative risk — New bill H.R. 8375 (Medicare Advantage Improvement Act of 2026) would tighten oversight, require less restrictive medical-necessity criteria and faster authorizations for Medicare Advantage plans, which could raise utilization and compliance costs for Centene. New Bill: H.R. 8375: Medicare Advantage Improvement Act of 2026
• Negative Sentiment: Membership mix pressure — несмотря strong Medicaid performance, Centene still faces declines in commercial/individual enrollment, which could limit revenue upside if persistent. Centene Stock Jumps With Medicaid Strength, But Commercial Enrollment Slide Persists

Institutional Trading of Centene

A number of institutional investors have recently modified their holdings of CNC. Addison Advisors LLC boosted its stake in shares of Centene by 455.6% in the third quarter. Addison Advisors LLC now owns 739 shares of the company’s stock valued at $26,000 after buying an additional 606 shares in the last quarter. DV Equities LLC acquired a new position in Centene during the fourth quarter worth $26,000. Mowery & Schoenfeld Wealth Management LLC acquired a new position in Centene during the third quarter worth $27,000. IFC & Insurance Marketing Inc. acquired a new position in Centene during the fourth quarter worth $28,000. Finally, SBI Securities Co. Ltd. raised its holdings in Centene by 118.4% during the fourth quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock worth $31,000 after purchasing an additional 406 shares during the last quarter. 93.63% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on CNC shares. Deutsche Bank Aktiengesellschaft raised their target price on Centene from $32.00 to $39.00 and gave the stock a “hold” rating in a research report on Tuesday, February 10th. The Goldman Sachs Group restated a “sell” rating and set a $40.00 price target on shares of Centene in a research note on Wednesday. Wall Street Zen downgraded Centene from a “buy” rating to a “hold” rating in a research note on Sunday, February 15th. TD Cowen raised their price target on Centene from $34.00 to $38.00 and gave the stock a “hold” rating in a research note on Wednesday, February 11th. Finally, Wells Fargo & Company set a $44.00 price target on Centene and gave the stock an “equal weight” rating in a research note on Wednesday, February 18th. Six equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, Centene currently has an average rating of “Hold” and an average target price of $49.76.

Centene Trading Up 8.8%

Shares of CNC stock opened at $53.94 on Thursday. The business’s 50 day moving average is $38.71 and its two-hundred day moving average is $39.35. Centene has a twelve month low of $25.08 and a twelve month high of $64.15. The company has a market capitalization of $26.53 billion, a P/E ratio of -3.96, a price-to-earnings-growth ratio of 0.96 and a beta of 0.59. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.87.

Centene (NYSE:CNC) last posted its quarterly earnings results on Tuesday, April 28th. The company reported $3.37 earnings per share for the quarter, beating analysts’ consensus estimates of $2.12 by $1.25. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The firm had revenue of $49.94 billion for the quarter, compared to the consensus estimate of $47.58 billion. During the same period in the previous year, the business earned $2.90 earnings per share. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. Equities analysts forecast that Centene will post 3.01 EPS for the current year.

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.